Anavex Life Sciences
AVXL
$12.96
Share price
8.82%
Change (1 day)
-48.88%
Change (1 year)
Categories
Market capitalization of Anavex Life Sciences (AVXL)
Market cap: $1.00 Billion
As of July 2022 Anavex Life Sciences has a market cap of $1.00 Billion. This makes Anavex Life Sciences the world's 4336th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Anavex Life Sciences from 2006 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.00 B | -23.89% |
| 2021 | $1.31 B | 264.53% |
| 2020 | $0.36 B | 144.59% |
| 2019 | $0.14 B | 102.12% |
| 2018 | $0.07 B | -48.63% |
| 2017 | $0.14 B | -9.22% |
| 2016 | $0.15 B | -18.74% |
| 2015 | $0.19 B | 1803.78% |
| 2014 | $0.01 B | 7.75% |
| 2013 | $9.41 M | -60.61% |
| 2012 | $0.02 B | -27.97% |
| 2011 | $0.03 B | -63.84% |
| 2010 | $0.09 B | 103% |
| 2009 | $0.04 B | -12.19% |
| 2008 | $0.05 B | -50.31% |
| 2007 | $0.10 B | 99.76% |
| 2006 | $0.05 B |
End of Day market cap according to different sources
On Jul 6th, 2022 the market cap of Anavex Life Sciences was reported to be:
$0.90 Billion
$0.92 Billion
$0.92 Billion
$0.92 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $1.65 B | 64.90% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $2.87 B | 186.91% | 🇺🇸 USA |
 Palatin Technologies PTN | $0.06 B | -93.65% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $2.23 B | 122.63% | 🇺🇸 USA |